SARAH VELLA: Open Payments
NPI 1578105888 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 14 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $569 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $121 |
| Janssen Biotech, Inc. | 3 | $68 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $62 |
| Genentech USA, Inc. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| SOBI, INC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Incyte Corporation | 1 | $18 |
| SERVIER PHARMACEUTICALS LLC | 1 | $16 |
Products named: Symbravo, ZYNLONTA, OPDIVO, Columvi, Itovebi, DARZALEX, Doptelet, ERLEADA.
Industry payments across MI — which companies pay providers there.
